Kaleido Biosciences Inc
OTC:KLDO
Cash Flow Statement
Cash Flow Statement
Kaleido Biosciences Inc
| Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||
| Net Income |
(38)
|
(40)
|
(51)
|
(62)
|
(71)
|
(83)
|
(88)
|
(86)
|
(86)
|
(80)
|
(81)
|
(82)
|
(85)
|
(90)
|
(90)
|
(90)
|
|
| Depreciation & Amortization |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
1
|
0
|
5
|
7
|
9
|
11
|
10
|
10
|
2
|
3
|
4
|
13
|
14
|
14
|
11
|
10
|
|
| Other Non-Cash Items |
1
|
2
|
5
|
8
|
10
|
12
|
11
|
10
|
11
|
12
|
13
|
14
|
15
|
15
|
12
|
11
|
|
| Cash Interest Paid |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Change in Working Capital |
5
|
5
|
4
|
7
|
1
|
2
|
2
|
(1)
|
2
|
(0)
|
0
|
5
|
0
|
1
|
4
|
(0)
|
|
| Cash from Operating Activities |
(32)
N/A
|
(33)
-5%
|
(41)
-22%
|
(46)
-14%
|
(60)
-29%
|
(69)
-16%
|
(74)
-7%
|
(76)
-2%
|
(71)
+6%
|
(67)
+5%
|
(66)
+2%
|
(62)
+7%
|
(68)
-10%
|
(72)
-6%
|
(71)
+1%
|
(77)
-8%
|
|
| Investing Cash Flow | |||||||||||||||||
| Capital Expenditures |
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(2)
|
(1)
|
(1)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(2)
N/A
|
(2)
+8%
|
(2)
-48%
|
(3)
-31%
|
(4)
-28%
|
(4)
-2%
|
(4)
+7%
|
(4)
+2%
|
(4)
+1%
|
(4)
-2%
|
(4)
-20%
|
(4)
+8%
|
(3)
+26%
|
(2)
+20%
|
(1)
+43%
|
(1)
+49%
|
|
| Financing Cash Flow | |||||||||||||||||
| Net Issuance of Common Stock |
111
|
102
|
102
|
101
|
99
|
69
|
68
|
68
|
0
|
35
|
37
|
41
|
109
|
76
|
74
|
70
|
|
| Net Issuance of Debt |
10
|
10
|
10
|
(0)
|
(0)
|
(0)
|
(0)
|
7
|
7
|
7
|
7
|
(0)
|
0
|
(0)
|
0
|
0
|
|
| Other |
0
|
(0)
|
(0)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
121
N/A
|
112
-8%
|
111
0%
|
99
-11%
|
97
-2%
|
66
-32%
|
67
+0%
|
75
+12%
|
7
-91%
|
42
+496%
|
43
+4%
|
40
-7%
|
109
+170%
|
75
-31%
|
74
-2%
|
70
-5%
|
|
| Change in Cash | |||||||||||||||||
| Net Change in Cash |
87
N/A
|
76
-12%
|
68
-11%
|
50
-27%
|
34
-32%
|
(7)
N/A
|
(11)
-71%
|
(5)
+58%
|
(67)
-1 320%
|
(29)
+57%
|
(27)
+8%
|
(25)
+6%
|
38
N/A
|
1
-98%
|
1
+18%
|
(8)
N/A
|
|
| Free Cash Flow | |||||||||||||||||
| Free Cash Flow |
(34)
N/A
|
(35)
-4%
|
(43)
-23%
|
(49)
-15%
|
(64)
-29%
|
(73)
-15%
|
(78)
-7%
|
(79)
-2%
|
(74)
+6%
|
(71)
+5%
|
(70)
+1%
|
(66)
+7%
|
(71)
-8%
|
(74)
-5%
|
(73)
+2%
|
(78)
-8%
|
|